| Literature DB >> 24127907 |
Gerben van Ooijen1, Sarah F Martin, Martin E Barrios-Llerena, Matthew Hindle, Thierry Le Bihan, John S O'Neill, Andrew J Millar.
Abstract
BACKGROUND: Casein Kinase 1 (CK1) is one of few proteins known to affect cellular timekeeping across metazoans, and the naturally occurring CK1tau mutation shortens circadian period in mammals. Functional conservation of a timekeeping function for CK1 in the green lineage was recently identified in the green marine unicell Ostreococcus tauri, in spite of the absence of CK1's transcriptional targets known from other species. The short-period phenotype of CK1tau mutant in mammals depends specifically on increased CK1 activity against PERIOD proteins. To understand how CK1 acts differently upon the algal clock, we analysed the cellular and proteomic effects of CK1tau overexpression in O. tauri.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24127907 PMCID: PMC3852742 DOI: 10.1186/1471-2121-14-46
Source DB: PubMed Journal: BMC Cell Biol ISSN: 1471-2121 Impact factor: 4.241
Figure 1Evident conservation of the tau mutant region across species. A) Multiple sequence alignment of part of the kinase domain of CK1 isoforms from circadian model organisms. An arrowhead indicates location of the tau mutant from Syrian hamster. B) Consensus logo generated from CK1 isoforms of circadian model organisms, for the region around the tau mutation.
Figure 2Overexpression of CK1induces long period rhythms. A) Free-running period was analysed in 6 independent transgenic lines overexpressing CK1TAU. Lines were compared against parent line CCA1-LUC in the identical plate position to the transgenic lines. In all cases, a significantly (p < 0.001) long circadian period was observed. B) Examples of traces of overexpression line CK1TAU-OX21 (red) compared to the parent line (black) in free-running conditions. C) Period increase (as in panel A) plotted against overexpression (densitometry of immunoblots, n = 3, as described in the Methods section), showing that in all transgenic lines, overexpression of the tau allele is associated with long period rhythms. D) Subtracted period lengthening of the six CK1tau mutant lines (red bars) compared to the parent line. Combined data of six previously published [18] independent overexpression lines of the wild-type CK1 allele were plotted for comparison (in blue).
Figure 3Reduced sensitivity to CK1 inhibitor IC261 in CK1-OX21. A) Dose–response curves of free-running period lengthening of CCA1-LUC (black line), CK1-OX8 (blue line), and CK1tau-OX21 (red line). CK1-OX8 results reproduced from [18] for direct comparison. B-C) For relevant IC261 concentrations, the averaged raw data (n = 8) is provided for CCA1-LUC parent cells (B) and CK1tau-OX21 cells (C). Black lines indicate the vehicle-treated controls, and blue lines represent inhibited cells. Dashed lines indicate SD (n = 8).
Figure 4Phospho-proteomic changes upon CK1overexpression. Volcano plot visualising quantified phosphopeptides in the parent line and in CK1tau-OX21. Blue datapoints represent significantly differential phospho-sites in a pairwise comparison; black circles represent those that do not change significantly. Criteria were p < 0.05 (horizontal line) and fold changes >1.5 or <0.67 (vertical lines). The identities of sites can be found in Additional file 1.
Figure 5Overlap between phospho-sites differential upon CK1and CK1 overexpression. Chord diagram showing the numbers of identified phospho-sites whose abundance significantly differs from the parent line (>1.5- or <0.67-fold change, p < 0.05, n = 5) in phospho-proteomic analysis described here (for CK1tau-OX21) and in ([18], for CK1-OX8). Shared chords represent overlap between the two data sets. Upregulated peptides are represented in dark blue, downregulated peptides in lighter blue.
List of predicted CK1 sites present among identified CK1-responsive phospho-sites
| | | | | | | | ** | *** | |
| 1 | L-asparaginase-like | S(p)LGLLPGPTK | Ot13g02360 | L-asparaginase | 1e-35 | 34% | AAH35836.1 | Yes (τ, A) | Yes (l, a, ba, ag) |
| 2 | Armadillo/plakoglobin | AAS(p)AEIASDYVATPGGSR | Ot15g02430 | Uridine-Cytidine Kinase 1-like | 3e-20 | 32% | EAW75186.1 | - | Yes (ba, a, d) |
| 3 | PI-4-phosphate 5-kinase | LRSS(p)VANVTAFATEEPL | Ot02g07550 | PI-4-phosphate 5-kinase | 2e-06 | 23% | AAC50916.1 | Yes (τ, A) | Yes (h, k, a, n) |
| 4 | Ankyrin repeats protein | AMQRGSS(p)LLDLQSADGGTPAMSAAAHSYGDVLQYLIEK | Ot08g01070 | Ankyrin repeat domain 17 | 2e-05 | 38% | AAH43394.1 | Yes (τ, A) | Yes (bs, l, n, h, s) |
| 5 | unnamed protein product | ASTLNDST(p)ADDGNVVR | Ot07g03300 | Ankyrin/Armadillo repeats protein | 0.014 | 24% | EAX10893.1 | - | - |
| 6 | unnamed protein product | EAFGDAS(p)DDDAFSPR | Ot14g01520 | Poliovirus receptor-related 4 | 1.6 | 32% | BAG61075.1 | Yes (τ, A) | Yes (n, d) |
| 7 | unnamed protein product | ET(p1)KT(p2,3)LAELMS(p3)INMGA* | Ot04g00360 | RNF181 | 1.8 | 42% | CCQ43543.1 | - | - |
| 8 | unnamed protein product | GGQEGS(p)PSKSLSSPK | Ot14g02110 | No similarity found | N/A | N/A | N/A | N/A | N/A |
| 9 | unnamed protein product | ALEDES(p)PVAVVKEK | Ot01g02950 | No similarity found | N/A | N/A | N/A | N/A | N/A |
| 10 | unnamed protein product | TKDAAEAS(p)DEDVVATR | Ot01g02280 | No similarity found | N/A | N/A | N/A | N/A | N/A |
| | | | | | | | | | |
| 11 | CDPK | SES(p)FAILTEAAK | Ot10g01030 | Death-associated protein kinase 3 | 2e-37 | 31% | NP_001339.1 | Yes (τ, A) | Yes (d, lu, hy) |
| | | | | | | | | | |
| 12 | Phox | AIS(p)PAPEER | Ot05g00090 | Sorting nexin 1, phox domain | 4e-13 | 22% | NP_003090.2 | Yes (τ, A) | Yes (d, l) |
| 13 | Trehalose-phosphate synthase | PADGST(p)PESPPRR | Ot01g02410 | H+ transporting ATPase | 5.8 | 35% | EAW99791.1 | Yes (τ) | Yes (lu, k, h) |
| | | | | | | | | | |
| 14 | putative TAF6 RNA polymerase | GT(p)TPDDDIGDAAAAHAPNVAVAETHV | Ot13g00540 | TAF6 RNA polymerase II | 4e-65 | 34% | EAW76588.1 | Yes (τ, A) | Yes (l, s, p, ag) |
| 15 | unnamed protein product | APAGAKPGITLPSNPFAAKPAT(p)KATPAAK | Ot14g01370 | Unknown protein | 2e-38 | 40% | AAH53854.1 | - | - |
| 16 | unnamed protein product | FGIVDGS(p)ASTETPETFVK | Ot08g03890 | Spondin 1 | 0.36 | 25% | AAH19825.1 | Yes (τ) | Yes (lu, n, d) |
| 17 | unnamed protein product | ALASDS(p)EDDERPR | Ot04g04920 | Importin beta | 1.1 | 38% | NP001263382.1 | - | - |
| 18 | unnamed protein product | TAS(p)PMTSPMASPSPAD | Ot17g01690 | 2,3-bisphosphoglycerate mutase | 9.2 | 33% | BAD92281.1 | Yes (τ, A) | Yes (n, sm, p, d) |
| 19 | unnamed protein product | SAS(p)YDSLLGAVPASTFPRPIPLAEMVR | Ot15g00280 | No similarity found | N/A | N/A | N/A | N/A | N/A |
List of CK1 sites based on site prediction that are present in the phospho-preoteome observed in this study and [18]. Parent proteins are listed for each peptide, along with their closest homolog in the human genome. Results are listed based on 1) their presence in significantly differentially regulated sites, and 2) Goodness of homology to closest human ortholog identified by BLAST searches. E values (E) and Maximum Identity (MI) are based on NCBI Blast. *This peptide is identified in three different phosphorylation states (p1, p2, p3), and all three are upregulated upon overexpression of either allele. ** [34], effects on period (t) and/or amplitude (A) upon knock-down in human cells. *** [36-41], rhythmic expression in following mouse cell types: liver (l), aorta (a), brown adipose (ba), adrenal gland (ag), distal colon (d), heart (h), kidney (k), NIH3T3 (n), brain stem (bs), SCN (s), lung (lu), hypothalamus (hy), pituitary (p), skeletal muscle (sm).
Figure 6Diurnal regulation of transcripts for parent proteins. Micro-array data from a publically available study [30] reveals diurnal expression profiles for all the transcripts encoding parent proteins from which CK1-responsive phospho-sites were identified that were part of a predicted CK1 target site.